Application of UCAD for Diagnosing Urothelial Carcinoma.
Condition(s):Urothelial Carcinoma; Diagnoses Disease; Chromosomal Abnormality; Urine MarkingLast Updated:June 26, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Urothelial Carcinoma; Diagnoses Disease; Chromosomal Abnormality; Urine MarkingLast Updated:June 26, 2019Unknown status
Condition(s):Bladder CancerLast Updated:August 6, 2019Completed
Condition(s):Transitional Cell Carcinoma; Bladder CancerLast Updated:May 7, 2021Not yet recruiting
Condition(s):Urinary Bladder NeoplasmsLast Updated:March 28, 2022Unknown status
Condition(s):Spinal Cord TumorLast Updated:January 10, 2023Recruiting
Condition(s):Bladder Cancer; Squamous Cell Carcinoma of the Bladder; Stage III Bladder Cancer; Stage IV Bladder Cancer; Transitional Cell Carcinoma of the BladderLast Updated:March 2, 2022Terminated
Condition(s):ToxicityLast Updated:December 27, 2022Completed
Condition(s):Bladder Urothelial Carcinoma; Muscle Invasive Bladder Carcinoma; Stage II Bladder Cancer AJCC v8; Stage IIIA Bladder Cancer AJCC v8Last Updated:February 7, 2024Recruiting
Condition(s):Heart Failure; Volume OverloadLast Updated:November 9, 2022Active, not recruiting
Condition(s):Bladder Cancer; Urine Marking; Diagnoses DiseaseLast Updated:June 20, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.